ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer
Ann Surg Oncol. 2023 Feb 6. doi: 10.1245/s10434-023-13149-4. Online ahead of print.NO ABSTRACTPMID:36745260 | DOI:10.1245/s10434-023-13149-4
Source: Ann Oncol - Category: Cancer & Oncology Authors: Kelly K Hunt Vera J Suman Hannah F Wingate A Marilyn Leitch Gary Unzeitig Judy C Boughey Funda Meric-Bernstam Matthew J Ellis John A Olson Source Type: research
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Neoadjuvant Therapy | Women